部份中文苯溴马隆处方资料(仅供参考) 藥名(學名) BENZBROMARONE 商品名 URINORM(【廠商】烏居) 劑型:50mg 类别名称 尿酸排泄薬 藥理作用: 高尿酸症、痛風、關節炎伴隨症狀、高血壓及心臟病引起約二次高尿酸症。 治療項目: 通常成人早餐時口服(100mg)6~8天後可達正常尿酸代謝值如期待快速之尿酸下降,可在早餐時口服(200mg),尿酸血中濃度恢復正常後改投與(100mg)。 用法用量: 通常成人1日200mg~300mg,分2~3次飯後服用。依年齡、症狀適宜增減之。 副作用: 通常授與本品不致有不良反應發生。很少的病患,偶而發生食物通過消化管速度過快之現象如有這種訴苦,停藥則可恢復正常,或可投與一些消管收斂藥劑。 注意事項: 不適於中度或高度的腎機能障礙者(腎盂絲球過濾速度在20ml/min以下者)。雖然在動物試驗本品不會引起催畸性,但對便孕婦女,不宜投與。 包装规格 25毫克 PTP包装:100片(10片×10),700片(14片×50),1000片(10片×100)
50毫克 PTP包装:100片(10片×10),500片(10片×50),700片(14片×50),1000片(10片×100)
瓶:1000片 包装
制造厂商 鸟居药业有限公司 URINORM Tab(Benzbromarone)苯溴马隆/ユリノーム錠
URINORM Tab. 25mg(ユリノーム錠25mg) Brand name : URINORM Tab. 25mg Active ingredient: Benzbromarone Dosage form: white tablet (φ: 6.5 mm, thickness: 2.1 mm) Print on wrapping: ユリノーム錠25mg, TO-082 25, URINORM Tab. 25mg URINORM Tab. 50mg(ユリノーム錠50mg) Brand name : URINORM Tab. 50mg Active ingredient: Benzbromarone Dosage form: white to pale yellow tablet (φ: 7.5 mm, thickness: 2.4 mm) Print on wrapping: ユリノーム錠50mg, TO-082 50, URINORM Tab. 50mg Effects of this medicine This medicine increases excretion of uric acid in the urine by inhibiting reabsorption of uric acid in renal tubules. It consequently improves hyperuricemia. It is usually used to treat gout, hypertension accompanied by hyperuricemia. Before using this medicine, be sure to tell your doctor and pharmacist •If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines. If you are a patient with liver damage, kidney stones, renal dysfunction. •If you are pregnant or breastfeeding. •If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) Dosing schedule (How to take this medicine) •Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>> •General dosage regimen: For gout, In general, for adults, take a half or 1 tablet (25 or 50 mg of the active ingredient) at a time, once a day. Then, as maintenance dose, take 1 tablet (50 mg) once to 3 times a day. For hypertension accompanied by hyperuricemia, In general, for adults, take 1 tablet (50 mg of the active ingredient) once to 3 times a day. In any case, the dosage should be adjusted according to the disease, age and symptoms. Strictly follow the instructions. •If you missed a dose, take a single dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule.You should never take two doses at one time. •If you accidentally took more than your prescribed dose, consult with your doctor or pharmacist. •Do not stop taking this medicine unless your doctor instructs you to do so. Precautions while taking this medicine •The periodical liver function test is carried out for the first six months from a medicine start. The liver function test may be performed on a regular basis on and after the sixth month. Do not miss appointments with your doctor. •If your urine has acidity, you are likely to develop symptoms such as uric acid stone, consequential hematuria, renal colic. For prevention, drink a lot of water to increase urinary volume and to alkalize it. Possible adverse reactions to this medicine The most commonly reported adverse reactions include discomfort in stomach, gastrointestinal disorder, itchiness, rash and diarrhea. If any of these symptoms occur, consult with your doctor or pharmacist. The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately. •loss of appetite, malaise, jaundice (yellowness in skin or in eyes) [serious liver damage] The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above. Storage conditions and other information •Keep out of the reach of children. Store away from light, heat and moisture. •Discard the remainder. Do not store them. Ask the pharmacist how to discard. Torii Pharmaceutical Co.,LtdInternal Revised: 11/2011 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. http://www.info.pmda.go.jp/go/pack/3949002F2114_1_06/ http://www.info.pmda.go.jp/go/pack/3949002F1053_1_06/
|